Repros to Present Androxal Data at 9th Men's Health World Congress

Repros Therapeutics (Nasdaq: RPRX ) today reported it will deliver an invited podium presentation at the 9th Men's Health World Congress entitled "Oral Enclomid (Androxal) Raises Total Serum Testosterone in Men with Secondary Hypogonadism: Comparison with a Topical Gel". The Men's Health World Congress, jointly sponsored by the American